Lv41
550 积分 2025-08-07 加入
Primary resistance to immunotherapy in patients with a dMMR/MSI metastatic gastrointestinal cancer: who is at risk? An AGEO real-world study
7小时前
待确认
Non-oncologic orphan drug approvals across the world: Types of evidence required and time to approval
8个月前
已完结
Impact Of Risk Evaluation And Mitigation Strategies On Generic Approvals Of US Pharmaceutical Products
9个月前
已完结
Impact Of Risk Evaluation And Mitigation Strategies On Generic Approvals Of US Pharmaceutical Products
9个月前
已完结
The Impact of Regulatory Reforms in China on Drug Lag: The Role of Clinical Development Strategies
1年前
已完结
皖公网安备34019202002308
